Volume 7, Issue 2 (Multidisciplinary Cancer Investigation 2023)                   Multidiscip Cancer Investig 2023, 7(2): 19-29 | Back to browse issues page

Ethics code: IR.UM.REC.1400.304


XML Print


1- Department of Psychology, Faculty of Education Sciences and Psychology, Ferdowsi University of Mashhad, Mashhad, Iran
2- Department of Psychology, Faculty of Education Sciences and Psychology, Ferdowsi University of Mashhad, Mashhad, Iran , mashhadi@um.ac.ir
Abstract:   (1752 Views)
Introduction: This study aimed to investigate the effectiveness of the Unified Protocol for Transdiagnostic Treatment of Emotional Disorders (UP) for women with breast cancer.
Methods: It was a pilot randomized controlled trial in which women with breast cancer were allocated to a 9-week Unified Protocol for transdiagnostic treatment of emotional disorders (UP) (n=14) or a wait-list control group (n=15). Pre-and post-intervention, the Beck Depression Scale (BDI-II), Beck Anxiety Scale (BAI), Depression, Anxiety and Stress Scale (DASS-21), Cognitive Flexibility Inventory, Cognitive Emotion Regulation Strategies Scale (CERQ), Emotional Awareness Level Scale (LEAS), and The EORTC Breast Cancer-Specific Quality of Life (EORTC QLQ-BR23) were completed.
Results: Significant reductions in depressive, anxiety, and stress symptoms, as well as maladaptive emotional regulation strategies, were observed within the UP from baseline to post-treatment. Compared to the waitlist-control condition, participants in the UP condition showed increased adaptive strategies of emotional regulation, cognitive flexibility, mindful emotional awareness, and quality of life.
Conclusions: The findings provide preliminary evidence for the utility of the UP in the reduction of psychological dysfunctions and improving the quality of life in women with breast cancer.
Full-Text [PDF 330 kb]   (2245 Downloads)    
Select article type: Original/Research Article |
Received: 2022/11/8 | Accepted: 2023/06/17 | ePublished: 2023/06/30

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.